Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance

por Echols, Roger, Ariyasu, Mari, Nagata, Tsutae Den
Publicado 2019

Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation

por Portsmouth, Simon, Echols, Roger, Toyoizumi, Kiichiro, Tillotson, Glenn, Nagata, Tsutae Den
Publicado 2021

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized,...

por Bassetti, Matteo, Ariyasu, Mari, Binkowitz, Bruce, Nagata, Tsutae Den, Echols, Roger M, Matsunaga, Yuko, Toyoizumi, Kiichiro, Doi, Yohei
Publicado 2019

1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections

por Matsunaga, Yuko, Sonoyama, Takuhiro, Casanova, Luis, Nagata, Tsutae Den, Echols, Roger, De Gregorio, Fabio, Ogura, Eriko, Portsmouth, Simon
Publicado 2020

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa

por Cai, Bin, Echols, Roger, Magee, Glenn, Arjona Ferreira, Juan Camilo, Morgan, Gareth, Ariyasu, Mari, Sawada, Takuko, Nagata, Tsutae “Den”
Publicado 2017